vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $89.1M, roughly 1.3× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -1.5%, a 8.9% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $8.1M).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

HROW vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.3× larger
RHLD
$117.7M
$89.1M
HROW
Higher net margin
HROW
HROW
8.9% more per $
HROW
7.4%
-1.5%
RHLD
More free cash flow
RHLD
RHLD
$181.2M more FCF
RHLD
$189.2M
$8.1M
HROW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
RHLD
RHLD
Revenue
$89.1M
$117.7M
Net Profit
$6.6M
$-1.7M
Gross Margin
79.3%
55.7%
Operating Margin
17.5%
30.2%
Net Margin
7.4%
-1.5%
Revenue YoY
33.3%
Net Profit YoY
-2.2%
EPS (diluted)
$0.20
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
RHLD
RHLD
Q4 25
$89.1M
$117.7M
Q3 25
$71.6M
$120.9M
Q2 25
$63.7M
$119.6M
Q1 25
$47.8M
$103.9M
Q4 24
$66.8M
Q3 24
$49.3M
Q2 24
$48.9M
Q1 24
$34.6M
Net Profit
HROW
HROW
RHLD
RHLD
Q4 25
$6.6M
$-1.7M
Q3 25
$1.0M
$-231.0K
Q2 25
$5.0M
$-611.0K
Q1 25
$-17.8M
$-3.4M
Q4 24
$6.8M
Q3 24
$-4.2M
Q2 24
$-6.5M
Q1 24
$-13.6M
Gross Margin
HROW
HROW
RHLD
RHLD
Q4 25
79.3%
55.7%
Q3 25
75.3%
59.0%
Q2 25
74.5%
57.5%
Q1 25
67.5%
52.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
RHLD
RHLD
Q4 25
17.5%
30.2%
Q3 25
20.6%
34.3%
Q2 25
17.9%
34.0%
Q1 25
-23.5%
24.7%
Q4 24
19.3%
Q3 24
2.7%
Q2 24
3.1%
Q1 24
-20.0%
Net Margin
HROW
HROW
RHLD
RHLD
Q4 25
7.4%
-1.5%
Q3 25
1.4%
-0.2%
Q2 25
7.8%
-0.5%
Q1 25
-37.2%
-3.2%
Q4 24
10.1%
Q3 24
-8.6%
Q2 24
-13.2%
Q1 24
-39.2%
EPS (diluted)
HROW
HROW
RHLD
RHLD
Q4 25
$0.20
$-0.20
Q3 25
$0.03
$-0.03
Q2 25
$0.13
$-0.07
Q1 25
$-0.50
$-0.39
Q4 24
$0.19
Q3 24
$-0.12
Q2 24
$-0.18
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$72.9M
$205.5M
Total DebtLower is stronger
$250.0M
$169.8M
Stockholders' EquityBook value
$52.4M
$6.5M
Total Assets
$399.5M
$333.4M
Debt / EquityLower = less leverage
4.77×
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
RHLD
RHLD
Q4 25
$72.9M
$205.5M
Q3 25
$74.3M
$148.0M
Q2 25
$53.0M
$99.9M
Q1 25
$66.7M
$71.0M
Q4 24
$47.2M
Q3 24
$72.6M
Q2 24
$71.0M
Q1 24
$76.0M
Total Debt
HROW
HROW
RHLD
RHLD
Q4 25
$250.0M
$169.8M
Q3 25
$347.2M
$173.4M
Q2 25
$250.6M
$177.1M
Q1 25
$256.9M
$180.7M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
RHLD
RHLD
Q4 25
$52.4M
$6.5M
Q3 25
$47.0M
$10.8M
Q2 25
$49.7M
$9.6M
Q1 25
$56.5M
$8.9M
Q4 24
$69.7M
Q3 24
$58.0M
Q2 24
$58.5M
Q1 24
$60.6M
Total Assets
HROW
HROW
RHLD
RHLD
Q4 25
$399.5M
$333.4M
Q3 25
$363.1M
$293.2M
Q2 25
$345.0M
$253.3M
Q1 25
$364.2M
$214.3M
Q4 24
$389.0M
Q3 24
$351.5M
Q2 24
$306.6M
Q1 24
$295.5M
Debt / Equity
HROW
HROW
RHLD
RHLD
Q4 25
4.77×
26.03×
Q3 25
7.39×
16.01×
Q2 25
5.05×
18.42×
Q1 25
4.55×
20.38×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
RHLD
RHLD
Operating Cash FlowLast quarter
$8.4M
$196.1M
Free Cash FlowOCF − Capex
$8.1M
$189.2M
FCF MarginFCF / Revenue
9.1%
160.8%
Capex IntensityCapex / Revenue
0.4%
5.8%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
RHLD
RHLD
Q4 25
$8.4M
$196.1M
Q3 25
$16.6M
$59.6M
Q2 25
$-803.0K
$48.9M
Q1 25
$19.7M
$18.4M
Q4 24
$-17.8M
Q3 24
$3.0M
Q2 24
$-2.7M
Q1 24
$-4.6M
Free Cash Flow
HROW
HROW
RHLD
RHLD
Q4 25
$8.1M
$189.2M
Q3 25
$16.4M
$58.6M
Q2 25
$-969.0K
$47.5M
Q1 25
$19.5M
$17.8M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
Q1 24
$-4.7M
FCF Margin
HROW
HROW
RHLD
RHLD
Q4 25
9.1%
160.8%
Q3 25
22.9%
48.5%
Q2 25
-1.5%
39.7%
Q1 25
40.8%
17.1%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Q1 24
-13.6%
Capex Intensity
HROW
HROW
RHLD
RHLD
Q4 25
0.4%
5.8%
Q3 25
0.3%
0.8%
Q2 25
0.3%
1.2%
Q1 25
0.4%
0.6%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Q1 24
0.3%
Cash Conversion
HROW
HROW
RHLD
RHLD
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons